Healthcare Access
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Gain critical insights into global pharmaceutical market access, pricing, reimbursement, and policy shifts impacting drug launches and patient affordability.
Showing 1–8 of 8 articles
Quick answer
NovaPharmaNews Healthcare Access hub for FDA covers 8 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
HFMA conference: Affordability was the focus, but fixes remained unclear
Pharmalittle: Roche accuses U.S. of 'blackmail,' Supreme Court rules on skinny labels
Opinion: The Virtual End of the Doctor's Office Waiting Room
OhioHealth and Fairfield Medical Center Terminate Merger Plans
Eli Lilly's 340B Data Mandate: A New Tactic in Pharma's Discount Program Battle
CMS and FDA Launch RAPID Coverage Pathway for Breakthrough Medical Devices Under Medicare
Amneal Pharmaceuticals Launches First Respiratory Inhalers: Albuterol and Beclomethasone HFA Products Now Available
Telemedicine Pharmaceutical Access: What You Need to Know (FDA Insights)
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.